PATENT CLAIM ANALYSIS

Application Number: 16237893
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-04
Patent Classification: ["530", "326000"]

Abstract:
The present invention provides modulators of complement activity. Also provided are methods of utilizing such modulators as therapeutics.

Claim (Index 4):
The C5 inhibitor polypeptide of  claim 3 , wherein the polypeptide of R 1  comprises the formula Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa6-Xaa7, wherein:\n Xaa1 is Cys or absent; Xaa2 is Val, Tbg, or is absent; Xaa3 is Glu, Nvl, or is absent; Xaa4 is selected from the group consisting of Arg, Cys, and Ser, or is absent; Xaa5 is Phe or Tyr; Xaa6 is Cys or Glu; and Xaa7 is Asp or Asn.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.17647
- Patent Class: 530.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16128561', '15318063', '15905158', '15547085', '14962457']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8394559725253506
- 35 USC 102 Novelty (BERT): 0.5890445374533099
- Combined Prediction Score: 0.8144148290181465
- Mean Citation Score: 504.10272
- Max Citation Score: 611.3871
- Similarity Product: 369.5773042693557

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test